title: Ginkgo biloba leaf extract improves the cognitive abilities of rats with D-galactose induced dementia.
abstract: Standardized Ginkgo biloba leaf extract has been used in clinical trials for its beneficial effects on brain functions, particularly in dementia. Substantial experimental evidences indicated that Ginkgo biloba leaf extract (EGB) protected neuronal cells from a variety of insults. We investigated the effect of EGB on cognitive ability and protein kinase B (PKB) activity in hippocampal neuronal cells of dementia model rats. Rats received an intraperitoneal injection of D-galactose to induce dementia. Forty-eight Spraque-Dawley rats were randomly divided into six groups, including the control group, D-galactose group (Gal), low-dose EGB group (EGB-L), mid-dose EGB group (EGB-M), high-dose EGB group (EGB-H) and treatment group. The EGB-L, EGB-M and EGB-H groups were administered with EGB and D-galactose simultaneously. Y-maze, cresyl violet staining, TUNEL assays and immunohistochemistry staining were performed to detect learning and memory abilities, morphological changes in the hippocampus, neuronal apoptosis and the expressing level of phospho-PKB, respectively. Rats in the Gal group showed decreased abilities of learning and memory, and hippocampal pyramidal cell layer was damaged, while EGB administration improved learning and memory abilities. The Gal group exhibited many stained, condensed nuclei and micronuclei, either isolated or within the cytoplasm of cells (39.5±1.4). Apoptotic cells decreased in the groups of EGB-L (35.9±0.9), EGB-M (16.8±1.0) and EGB-H (10.1±0.8), and there were statistical significances compared with the Gal group. Immunoreactivity of phospho-PKB was localized diffusely throughout the cytosol of cells in all groups, while the immunoreactivity of the Gal group was weak. EGB significantly attenuated learning and memory impairment in a dose-dependent manner, while it could decrease the nmber of TUNEL-positive cells, and increase the activity of PKB. Our results demonstrated that EGB attenuated memory impairment and cell apoptosis in galactose-induced dementia model rats by activating PKB.
authors.affiliation: Department of Neurology, the First People's Hospital, Xuzhou, Jiangsu 221002, China;
authors.forename: Nuan
authors.initials: N
authors.lastname: Wang
authors.forename: Xianming
authors.initials: X
authors.lastname: Chen
authors.forename: Deqin
authors.initials: D
authors.lastname: Geng
authors.forename: Hongli
authors.initials: H
authors.lastname: Huang
authors.forename: Hao
authors.initials: H
authors.lastname: Zhou
keywords: D-galactose; Ginkgo biloba extract; apoptosis; cognitive ability; dementia model; protein kinase B (PKB)
references.citation: Int J Cell Biol. 2012;2012:735206
references.pmid: 22701485
references.citation: Neuroscience. 2011 Apr 28;180:248-55
references.pmid: 21334424
references.citation: Arzneimittelforschung. 2007;57(1):4-11
references.pmid: 17341003
references.citation: Neuropsychobiology. 2002;45(1):19-26
references.pmid: 11803237
references.citation: J Neuropathol Exp Neurol. 2004 Mar;63(3):255-61
references.pmid: 15055449
references.citation: Exp Gerontol. 2006 Jun;41(6):628-34
references.pmid: 16716550
references.citation: Neuroscientist. 2005 Feb;11(1):10-5
references.pmid: 15632274
references.citation: BMC Geriatr. 2010 Mar 17;10:14
references.pmid: 20236541
references.citation: Curr Drug Targets. 2000 Jul;1(1):25-58
references.pmid: 11475535
references.citation: Curr Opin Neurobiol. 2001 Jun;11(3):297-305
references.pmid: 11399427
references.citation: J Clin Neurosci. 2007 Apr;14(4):301-8
references.pmid: 17276069
references.citation: Neurol Res. 2005 Jul;27(5):552-6
references.pmid: 15978184
references.citation: PLoS One. 2011;6(12):e29102
references.pmid: 22220203
references.citation: Cochrane Database Syst Rev. 2001;(2):CD001498
references.pmid: 11405995
references.citation: Curr Opin Psychiatry. 2012 May;25(3):226-30
references.pmid: 22327552
references.citation: J Ethnopharmacol. 2006 Mar 8;104(1-2):250-6
references.pmid: 16219437
references.citation: Brain Res Mol Brain Res. 2001 Jan 31;86(1-2):76-83
references.pmid: 11165374
references.citation: Front Biosci. 2004 Sep 01;9:3091-104
references.pmid: 15353340
references.citation: J Psychiatr Res. 2012 Jun;46(6):716-23
references.pmid: 22459264
references.citation: Oncogene. 2008 Sep 18;27(41):5486-96
references.pmid: 18794883
references.citation: Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6577-80
references.pmid: 11381109
references.citation: Biochem J. 2000 Mar 15;346 Pt 3:561-76
references.pmid: 10698680
references.citation: J Neurochem. 2001 Sep;78(5):1000-8
references.pmid: 11553674
references.citation: Life Sci. 1999;65(2):157-64
references.pmid: 10416821
references.citation: J Neurosci Res. 2006 Aug 15;84(3):647-54
references.pmid: 16710848
references.citation: Pharmacopsychiatry. 2010 May;43(3):86-91
references.pmid: 20104449